DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nexavar (Sorafenib) - News

 
 



News related to Nexavar (Sorafenib) and/or conditions it is approved for

Sunitinib, sorafenib of no benefit in ECOG-ACRIN renal cell trial
Source: Cancer / Oncology News From Medical News Today [2015.02.26]
Research results highlighted at the press conference of a major medical meeting report no benefit from the use of either Sutent® (sunitinib) or Nexavar® (sorafenib) among patients with...

Adjuvant sorafenib and sunitinib do not improve outcomes in locally advanced kidney cancer
Source: Cancer / Oncology News From Medical News Today [2015.02.26]
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib.

VEGF Inhibitors Disappoint in Adjuvant Renal Cell Carcinoma
Source: Medscape Hematology-Oncology Headlines [2015.02.24]
Sorafenib and sunitinib do not prolong disease-free survival in patients with completely resected, locally advanced kidney cancer at high risk for recurrence.
Medscape Medical News

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015